R

R&G PharmaStudies Co Ltd
SZSE:301333

Watchlist Manager
R&G PharmaStudies Co Ltd
SZSE:301333
Watchlist
Price: 51.88 CNY 1.63%
Market Cap: 5B CNY
Have any thoughts about
R&G PharmaStudies Co Ltd?
Write Note

R&G PharmaStudies Co Ltd
Other Operating Expenses

Last Value
3-Years 3-Y CAGR
5-Years 5-Y CAGR
10-Years 10-Y CAGR
Quarterly
Annual
TTM
|

R&G PharmaStudies Co Ltd
Other Operating Expenses Peer Comparison

Competitors Analysis
Latest Figures & CAGR of Competitors

Company Other Operating Expenses CAGR 3Y CAGR 5Y CAGR 10Y
R
R&G PharmaStudies Co Ltd
SZSE:301333
Other Operating Expenses
ÂĄ12.3m
CAGR 3-Years
10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
WuXi AppTec Co Ltd
SSE:603259
Other Operating Expenses
ÂĄ358m
CAGR 3-Years
34%
CAGR 5-Years
18%
CAGR 10-Years
N/A
Pharmaron Beijing Co Ltd
SZSE:300759
Other Operating Expenses
ÂĄ74m
CAGR 3-Years
21%
CAGR 5-Years
25%
CAGR 10-Years
N/A
WuXi Biologics (Cayman) Inc
HKEX:2269
Other Operating Expenses
ÂĄ404.5m
CAGR 3-Years
31%
CAGR 5-Years
15%
CAGR 10-Years
N/A
Hangzhou Tigermed Consulting Co Ltd
SZSE:300347
Other Operating Expenses
ÂĄ16.8m
CAGR 3-Years
10%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
W
WuXi XDC Cayman Inc
HKEX:2268
Other Operating Expenses
ÂĄ45.3m
CAGR 3-Years
3%
CAGR 5-Years
N/A
CAGR 10-Years
N/A
No Stocks Found

R&G PharmaStudies Co Ltd
Glance View

Market Cap
5B CNY
Industry
Life Sciences Tools & Services

R&G PharmaStudies Co., Ltd. engages in the provision of clinical trial outsourcing services. The company is headquartered in Beijing, Beijing and currently employs 1,926 full-time employees. The company went IPO on 2022-08-02. The firm's main businesses include clinical trial operation services (CO Services), clinical trial site management services (SMO Services), biological sample testing services (BA Services), data management and statistical analysis services (DM/ST Services), clinical trials Consulting Services, Clinical Pharmacology Services (CP Services) and others. The firm operates its businesses primarily in the domestic market.

Intrinsic Value
59.36 CNY
Undervaluation 13%
Intrinsic Value
Price
R

See Also

What is R&G PharmaStudies Co Ltd's Other Operating Expenses?
Other Operating Expenses
12.3m CNY

Based on the financial report for Dec 31, 2023, R&G PharmaStudies Co Ltd's Other Operating Expenses amounts to 12.3m CNY.

What is R&G PharmaStudies Co Ltd's Other Operating Expenses growth rate?
Other Operating Expenses CAGR 3Y
10%

Over the last year, the Other Operating Expenses growth was 127%. The average annual Other Operating Expenses growth rates for R&G PharmaStudies Co Ltd have been 10% over the past three years .

Back to Top